417 related articles for article (PubMed ID: 28842265)
1. Identification of broadly neutralizing monoclonal antibodies against Crimean-Congo hemorrhagic fever virus.
Zivcec M; Guerrero LIW; Albariño CG; Bergeron É; Nichol ST; Spiropoulou CF
Antiviral Res; 2017 Oct; 146():112-120. PubMed ID: 28842265
[TBL] [Abstract][Full Text] [Related]
2. Establishment of two serological methods for detecting IgG and neutralizing antibodies against Crimean-Congo hemorrhagic fever virus glycoprotein.
Wang Q; Wang S; Shi Z; Li Z; Zhao Y; Feng N; Wang T; Yan F; Xia X
Front Cell Infect Microbiol; 2024; 14():1341332. PubMed ID: 38746783
[TBL] [Abstract][Full Text] [Related]
3. Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice.
Hinkula J; Devignot S; Åkerström S; Karlberg H; Wattrang E; Bereczky S; Mousavi-Jazi M; Risinger C; Lindegren G; Vernersson C; Paweska J; van Vuren PJ; Blixt O; Brun A; Weber F; Mirazimi A
J Virol; 2017 May; 91(10):. PubMed ID: 28250124
[TBL] [Abstract][Full Text] [Related]
4. Pseudo-plaque reduction neutralization test (PPRNT) for the measurement of neutralizing antibodies to Crimean-Congo hemorrhagic fever virus.
Canakoglu N; Berber E; Ertek M; Yoruk MD; Tonbak S; Bolat Y; Aktas M; Kalkan A; Ozdarendeli A
Virol J; 2013 Jan; 10():6. PubMed ID: 23282186
[TBL] [Abstract][Full Text] [Related]
5. Nucleoside-Modified mRNA Vaccines Protect IFNAR
Appelberg S; John L; Pardi N; Végvári Á; Bereczky S; Ahlén G; Monteil V; Abdurahman S; Mikaeloff F; Beattie M; Tam Y; Sällberg M; Neogi U; Weissman D; Mirazimi A
J Virol; 2022 Feb; 96(3):e0156821. PubMed ID: 34817199
[TBL] [Abstract][Full Text] [Related]
6. A competitive ELISA for species-independent detection of Crimean-Congo hemorrhagic fever virus specific antibodies.
Schuster I; Mertens M; Köllner B; Korytář T; Keller M; Hammerschmidt B; Müller T; Tordo N; Marianneau P; Mroz C; Rissmann M; Stroh E; Dähnert L; Hammerschmidt F; Ulrich RG; Groschup MH
Antiviral Res; 2016 Oct; 134():161-166. PubMed ID: 27623345
[TBL] [Abstract][Full Text] [Related]
7. Fine mapping epitope on glycoprotein Gc from Crimean-Congo hemorrhagic fever virus.
Zhang J; Simayi A; Wang M; Moming A; Xu W; Wang C; Li Y; Ding J; Deng F; Zhang Y; Sun S
Comp Immunol Microbiol Infect Dis; 2019 Dec; 67():101371. PubMed ID: 31627038
[TBL] [Abstract][Full Text] [Related]
8. Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever.
Rodriguez SE; Cross RW; Fenton KA; Bente DA; Mire CE; Geisbert TW
Sci Rep; 2019 May; 9(1):7755. PubMed ID: 31123310
[TBL] [Abstract][Full Text] [Related]
9. GP38-targeting monoclonal antibodies protect adult mice against lethal Crimean-Congo hemorrhagic fever virus infection.
Golden JW; Shoemaker CJ; Lindquist ME; Zeng X; Daye SP; Williams JA; Liu J; Coffin KM; Olschner S; Flusin O; Altamura LA; Kuehl KA; Fitzpatrick CJ; Schmaljohn CS; Garrison AR
Sci Adv; 2019 Jul; 5(7):eaaw9535. PubMed ID: 31309159
[TBL] [Abstract][Full Text] [Related]
10. Cellular localization and antigenic characterization of crimean-congo hemorrhagic fever virus glycoproteins.
Bertolotti-Ciarlet A; Smith J; Strecker K; Paragas J; Altamura LA; McFalls JM; Frias-Stäheli N; García-Sastre A; Schmaljohn CS; Doms RW
J Virol; 2005 May; 79(10):6152-61. PubMed ID: 15858000
[TBL] [Abstract][Full Text] [Related]
11. Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever.
Fels JM; Maurer DP; Herbert AS; Wirchnianski AS; Vergnolle O; Cross RW; Abelson DM; Moyer CL; Mishra AK; Aguilan JT; Kuehne AI; Pauli NT; Bakken RR; Nyakatura EK; Hellert J; Quevedo G; Lobel L; Balinandi S; Lutwama JJ; Zeitlin L; Geisbert TW; Rey FA; Sidoli S; McLellan JS; Lai JR; Bornholdt ZA; Dye JM; Walker LM; Chandran K
Cell; 2021 Jun; 184(13):3486-3501.e21. PubMed ID: 34077751
[TBL] [Abstract][Full Text] [Related]
12. Crimean-Congo Hemorrhagic Fever Virus, Mongolia, 2013-2014.
Voorhees MA; Padilla SL; Jamsransuren D; Koehler JW; Delp KL; Adiyadorj D; Baasandagwa U; Jigjav B; Olschner SP; Minogue TD; Schoepp RJ
Emerg Infect Dis; 2018 Dec; 24(12):2202-2209. PubMed ID: 30457521
[TBL] [Abstract][Full Text] [Related]
13. Structural characterization of protective non-neutralizing antibodies targeting Crimean-Congo hemorrhagic fever virus.
Durie IA; Tehrani ZR; Karaaslan E; Sorvillo TE; McGuire J; Golden JW; Welch SR; Kainulainen MH; Harmon JR; Mousa JJ; Gonzalez D; Enos S; Koksal I; Yilmaz G; Karakoc HN; Hamidi S; Albay C; Spengler JR; Spiropoulou CF; Garrison AR; Sajadi MM; Bergeron É; Pegan SD
Nat Commun; 2022 Nov; 13(1):7298. PubMed ID: 36435827
[TBL] [Abstract][Full Text] [Related]
14. Molecular and serological findings in suspected patients with Crimean-Congo hemorrhagic fever virus in Iran.
Karlberg H; Sharifi-Mood B; Mousavi-Jazi M; Dilcher M; Lindegren G; Mardani M; Bereskly S; Weidmann M; Mirazimi A
J Med Virol; 2015 Apr; 87(4):686-93. PubMed ID: 25649667
[TBL] [Abstract][Full Text] [Related]
15. Bovine Herpesvirus Type 4 (BoHV-4) Vector Delivering Nucleocapsid Protein of Crimean-Congo Hemorrhagic Fever Virus Induces Comparable Protective Immunity against Lethal Challenge in IFNα/β/γR-/- Mice Models.
Aligholipour Farzani T; Földes K; Hanifehnezhad A; Yener Ilce B; Bilge Dagalp S; Amirzadeh Khiabani N; Ergünay K; Alkan F; Karaoglu T; Bodur H; Ozkul A
Viruses; 2019 Mar; 11(3):. PubMed ID: 30857305
[TBL] [Abstract][Full Text] [Related]
16. A novel double-antigen sandwich ELISA for the species-independent detection of Crimean-Congo hemorrhagic fever virus-specific antibodies.
Sas MA; Comtet L; Donnet F; Mertens M; Vatansever Z; Tordo N; Pourquier P; Groschup MH
Antiviral Res; 2018 Mar; 151():24-26. PubMed ID: 29330092
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Inhibitors of Pathogenic Crimean-Congo Hemorrhagic Fever Virus Strains Using Virus-Like Particles.
Zivcec M; Metcalfe MG; Albariño CG; Guerrero LW; Pegan SD; Spiropoulou CF; Bergeron É
PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004259. PubMed ID: 26625182
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse model.
Pavel STI; Yetiskin H; Kalkan A; Ozdarendeli A
PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008834. PubMed ID: 33226988
[TBL] [Abstract][Full Text] [Related]
19. Presence of broadly reactive and group-specific neutralizing epitopes on newly described isolates of Crimean-Congo hemorrhagic fever virus.
Ahmed AA; McFalls JM; Hoffmann C; Filone CM; Stewart SM; Paragas J; Khodjaev S; Shermukhamedova D; Schmaljohn CS; Doms RW; Bertolotti-Ciarlet A
J Gen Virol; 2005 Dec; 86(Pt 12):3327-3336. PubMed ID: 16298978
[TBL] [Abstract][Full Text] [Related]
20. Epitope-mapping of the glycoprotein from Crimean-Congo hemorrhagic fever virus using a microarray approach.
Fritzen A; Risinger C; Korukluoglu G; Christova I; Corli Hitzeroth A; Viljoen N; Burt FJ; Mirazimi A; Blixt O
PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006598. PubMed ID: 29985929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
